Unsupported Browser. Please use Google Chrome, Mozilla Firefox,
or Microsoft Edge to submit meeting requests. Microsoft Internet Explorer is not
supported due to its outdated JavaScript engine.
-
Interview with Juergen Horn, Invetx - Part of the Name Tag Series
-
Interview with Jonathan Solomon, BiomX - Part of the Nametag Series
-
Interview with Dale Chappell, Humanigen - Part of the Nametag Series
-
Interview with Jonathan Drachman, Neoleukin Therapeutics - Part of the Nametag Series
-
Interview with Brandi Roberts, Lineage Cell Therapeutics - Part of the Nametag Series
-
Interview with Richard Godfrey, BerGenBio - Part of the NameTag Series - Update
-
Interview with Pawel Przewiezlikowski, Ryvu - Part of the Name Tag Series
-
Interview with David Parkinson, ESSA Pharma - Part of the Name Tag Series
-
Interview with Lucy Lu, Kintor Pharmaceutical - Part of the Name Tag Series
-
Interview with Theresa Heah, Asclepix - Part of the NameTag Series
-
Interview with Alex Zapesochny, Clerio Vision - Part of the NameTag Series
-
Interview with Vishal Doshi, AUM Biosciences - Part of the NameTag Series
-
Interview with Niquette Hunt, Candesant - Part of the NameTag Series
-
Interview with Zach Hornby, Boundless Bio - Part of the NameTag Series
-
Interview with Bob Geho, Diasome - Part of the NameTag Series
-
Interview with Bill Enright, Vaccitech - Part of the NameTag Series
-
Interview with Richard Andrews, Azitra - Part of the NameTag Series
-
Check out the latest podcast in the NameTag series with Takashi Kei Kishimoto from Selecta Bio
-
Interview with Melissa Epperly, Zentalis - Part of the NameTag Series
-
Interview with Richard Godfrey, BerGenBio - Part of the NameTag Series
-
Interview with Gerben Moolhuizen, ISA Pharmaceuticals - Part of the NameTag Series
-
Interview with Brian Culley, Lineage Cell Therapeutics - Part of the NameTag Series
-
Interview with Antonin De Fougerolles, Evox - Part of the NameTag
-
Interview with Laura Benjamin, Oncologie - Part of the NameTag Series
-
Interview with Frank Borriello, Alloplex - Part of the NameTag Series
-
Interview with Adi Hoess, Affimed - Part of the NameTag Series
-
Interview with Ralph Kern, BrainStorm - Part of the NameTag Series
-
Interview with David Hilbert, Arcellx - Part of the NameTag Series
-
Interview with Dean Hum, Genfit - Part of the NameTag Series
-
Interview with David Shao, Yisheng Biopharma - Part of the NameTag Series
-
Interview with Maria Fardis, Iovance - Part of the NameTag Series
-
Interview with Wolfgang Soehgen, Paion AG - Part of the NameTag Series
-
ASH 2018 Debrief with Michel Sadelain (MSKCC), Catherine Diefenbach (NYU), and Ivan Borrello (Hopkins): Discussing data for CAR-T, Lymphoma, and Myeloma
-
TroutTalks Ep 18: AACR preview with Michel Sadelain and John Heymach Discussing Lung Cancer Showdown, CAR-T Data Plethora
-
TroutTalks Ep 17: Prof. Gary Anderson - Anticalins
-
TroutTalks Ep 16: Dr. Sameer Bansilal - PCSK9 Inhibitor - Presented by the American Heart Association
-
TroutTalks Ep15: Marcela Maus & Chuck Drake - 2nd Annual 2017 AACR Preview KOL Talk
-
TroutTalks Ep 14: Dr. Philip Greenberg - "Engineering T Cells to be Effective in Tumor Therapy "
-
TroutTalks Ep 13: 2nd Annual ASH Preview with Dr. Joshua Brody and Dr. Anne Renteria
-
TroutTalks Ep12: Dr. Peter Hotez - Zika Pandemic
-
TroutTalks Ep11: Louis Matis - CDO of Pieris talks about his past career and the advantages of Anticalins
-
TroutTalks Ep10: Dr. Chrystal Mackall - "Immunotherapy A New Paradigm in Cancer Treatment "
-
TroutTalks Ep9: Dr. John Bell - "Oncolytic Viruses: Biological Machines for Cancer Therapy"
-
TroutTalks Ep7: Dr. Michael Young - "Science of Human Retinal Progenitor Cell Therapy"
-
TroutTalks Ep8: Dr. Eric Pierce - "Treatment of Human Retinal Progenitor with Cell Therapy"
-
TroutTalks Ep 5: Dr. Marcela V. Maus - "AACR Preview: CARs and Constructs"
-
TroutTalks Ep 6: Dr Charles G. Drake - "AACR Preview: Bispecifics and Check-Points"
-
TroutTalks Ep 4: Dr. Leisha Emens - "Breast Cancer Vaccines"
-
TroutTalks Ep 3: Dr. Louis Weiner - "Antibody Therapy of Cancer: The Revolution Continues”
-
TroutTalks Ep 2: Dr. Dario Vignali - "Targeting T-Regs with a focus on LAG-3"
